— Know what they know.
Not Investment Advice

0A0D.IL IOB

Alcon AG
1W: -1.1% 1M: -10.0% YTD: -3.4%
CHF 52.86 ($63.83)
-1.09 (-2.02%)
 
Weekly Expected Move ±2.7%
CHF 50 CHF 51 CHF 53 CHF 54 CHF 56
IOB · Healthcare · Medical - Specialties · Tech Score Sell · Power 44 · CHF 25.8B mcap · 487M float · 0.088% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market CapCHF 25.8B ($31.1B)
52W Range48.08-79.39
Volume24,807
Avg Volume427,903
Beta0.93
DividendCHF 0.28
Analyst Ratings
14 Buy 7 Hold 2 Sell
Consensus Buy
Company Info
CEODavid J. Endicott
Employees25,942
SectorHealthcare
IndustryMedical - Specialties
IPO Date2021-02-10
Websitealcon.com
Chemin de Blandonnet 8
Geneva, GE 1214
CH
41 58 911 20 00
About Alcon AG

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms